These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 394320)

  • 1. [Discontinuation of chronic hemodialysis due to improved kidney function caused by the control of arterial hypertension].
    Wauters JP; Schaller MD; Brunner HR
    Schweiz Med Wochenschr; 1979 Dec; 109(47):1873-5. PubMed ID: 394320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathophysiology and prognosis in malignant hypertension: comparison by underlying diseases].
    Kawazoe N
    Fukuoka Igaku Zasshi; 1989 Oct; 80(10):467-76. PubMed ID: 2515135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypertension in hemodialysis patients in Andalucia].
    García Cortés MJ; Ceballos M;
    Nefrologia; 2004; 24(2):149-57. PubMed ID: 15219090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term treatment with captopril in arterial hypertension complicated by renal failure].
    Durand D; Ader JL; Emal V; Bories P; Girolami JP; Suc JM
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():151-6. PubMed ID: 6126168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relative roles of sodium and renin in the hypertension of renal disease. An assessment based on the response to frusemide and propranolol.
    Wilkinson R; Sellars L; Pickering M; Robson V; Kerr DN
    Clin Nephrol; 1981 Dec; 16(6):307-13. PubMed ID: 7032775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of arterial hypertension in progression of renal failure.
    Kes P; Ratković-Gusić I
    Kidney Int Suppl; 1996 Jun; 55():S72-4. PubMed ID: 8743515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term renal function preservation after renal artery stenting in patients with progressive ischemic nephropathy.
    Rocha-Singh KJ; Ahuja RK; Sung CH; Rutherford J
    Catheter Cardiovasc Interv; 2002 Oct; 57(2):135-41. PubMed ID: 12357507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of minoxidil in the treatment of malignant hypertension in chronic renal failure.
    Mutterperl RE; Diamond FB; Lowenthal DT
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):498-509. PubMed ID: 789412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncontrollable hypertension in patients on hemodialysis: long-term treatment with captopril and salt subtraction.
    Wauters JP; Waeber B; Brunner HR; Guignard JP; Turini GA; Gavras H
    Clin Nephrol; 1981 Aug; 16(2):86-92. PubMed ID: 6266727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Resolution of scleroderma renal crisis with thrombotic microangiopathy. Case report (author's transl)].
    Rebaiz K; Birembaut P; Charneau A; Petit J; Wolf C
    Nephrologie; 1980; 1(3):137-41. PubMed ID: 7027064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of diuretics in treatment of hypertension secondary to renal disease.
    Bank N; Lief PD; Piczon O
    Arch Intern Med; 1978 Oct; 138(10):1524-9. PubMed ID: 708175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognosis of malignant hypertension; difference between underlying diseases such as essential hypertension and chronic glomerulonephritis.
    Kawazoe N; Eto T; Abe I; Takishita S; Ueno M; Kobayashi K; Uezono K; Muratani H; Kimura Y; Tomita Y
    Clin Nephrol; 1988 Feb; 29(2):53-7. PubMed ID: 3359695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of arterial pressure and age on renal function, The "Care for the Kidney" study].
    Olivares J; Guillén F; Sánchez JJ; Morales-Olivas FJ
    Nefrologia; 2003; 23(2):137-44. PubMed ID: 12778878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors of renal failure progression two years prior to dialysis.
    Mazouz H; Kacso I; Ghazali A; El Esper N; Moriniere P; Makdassi R; Hardy P; Westeel PF; Achard JM; Pruna A; Fournier A
    Clin Nephrol; 1999 Jun; 51(6):355-66. PubMed ID: 10404696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term renal function in primary hypertension. An epidemiological and pathophysiological study.
    Siewert-Delle A
    Scand J Urol Nephrol Suppl; 1999; 199():1-36. PubMed ID: 10349677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
    Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
    J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
    Bailey RR; Shand BI; Smith AH; Robson RA; Lynn KL
    Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.